Zhende Medical Co., Ltd.

Shanghai Stock Exchange 603301.SS

Zhende Medical Co., Ltd. Dividends Paid for the year ending December 31, 2023: USD -59.68 M

Zhende Medical Co., Ltd. Dividends Paid is USD -59.68 M for the year ending December 31, 2023, a -202.11% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.
  • Zhende Medical Co., Ltd. Dividends Paid for the year ending December 31, 2022 was USD -19.75 M, a 75.98% change year over year.
  • Zhende Medical Co., Ltd. Dividends Paid for the year ending December 31, 2021 was USD -82.24 M, a -791.74% change year over year.
  • Zhende Medical Co., Ltd. Dividends Paid for the year ending December 31, 2020 was USD -9.22 M, a -83.50% change year over year.
  • Zhende Medical Co., Ltd. Dividends Paid for the year ending December 31, 2019 was USD -5.03 M, a -64.48% change year over year.
Key data
Date Dividends Paid Capital Expenditure Other Financing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
SV Wall Street
Shanghai Stock Exchange: 603301.SS

Zhende Medical Co., Ltd.

CEO Mr. Jianguo Lu
IPO Date April 27, 2018
Location China
Headquarters Gaobei Industrial Zone
Employees 6,717
Sector Consumers Staples
Industries
Description

Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment. It offers medical wound dressing products, sensory control protection products, pressure therapy and immobilization products, and stoma and chronic wounds, and home care products. The company sells its products approximately in 73 countries, including Europe, the United States, and China. The company was founded in 1994 and is based in Shaoxing, China.

Similar companies

300677.SZ

Intco Medical Technology Co., Ltd.

USD 3.75

-0.75%

688298.SS

Zhejiang Orient Gene Biotech Co., Ltd.

USD 3.96

0.36%

002382.SZ

Blue Sail Medical Co.,Ltd.

USD 0.66

-0.09%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 3.37

-1.70%

StockViz Staff

February 2, 2025

Any question? Send us an email